Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations.

The identification of a hexanucleotide repeat expansion in the C9ORF72 gene as the cause of chromosome 9-linked frontotemporal dementia and motor neuron disease offers the opportunity for greater understanding of the relationship between these disorders and other clinical forms of frontotemporal lobar degeneration. In this study, we screened a cohort of 398 patients with frontotemporal dementia, progressive non-fluent aphasia, semantic dementia or mixture of these syndromes for mutations in the C9ORF72 gene. Motor neuron disease was present in 55 patients (14%). We identified 32 patients with C9ORF72 mutations, representing 8% of the cohort. The patients' clinical phenotype at presentation varied: nine patients had frontotemporal dementia with motor neuron disease, 19 had frontotemporal dementia alone, one had mixed semantic dementia with frontal features and three had progressive non-fluent aphasia. There was, as expected, a significant association between C9ORF72 mutations and presence of motor neuron disease. Nevertheless, 46 patients, including 22 familial, had motor neuron disease but no mutation in C9ORF72. Thirty-eight per cent of the patients with C9ORF72 mutations presented with psychosis, with a further 28% exhibiting paranoid, deluded or irrational thinking, whereas <4% of non-mutation bearers presented similarly. The presence of psychosis dramatically increased the odds that patients carried the mutation. Mutation bearers showed a low incidence of motor stereotypies, and relatively high incidence of complex repetitive behaviours, largely linked to patients' delusions. They also showed a lower incidence of acquired sweet food preference than patients without C9ORF72 mutations. Post-mortem pathology in five patients revealed transactive response DNA-binding protein 43 pathology, type A in one patient and type B in three. However, one patient had corticobasal degeneration pathology. The findings indicate that C9ORF72 mutations cause some but not all cases of frontotemporal dementia with motor neuron disease. Other mutations remain to be discovered. C9ORF72 mutations are associated with variable clinical presentations and pathology. Nevertheless, the findings highlight a powerful association between C9ORF72 mutations and psychosis and suggest that the behavioural characteristics of patients with C9ORF72 mutations are qualitatively distinct. Mutations in the C9ORF72 gene may be a major cause not only of frontotemporal dementia with motor neuron disease but also of late onset psychosis.

[1]  T. Ferman,et al.  Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72 , 2011, Acta Neuropathologica.

[2]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[3]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[4]  Julie S Snowden,et al.  The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. , 2011, Brain : a journal of neurology.

[5]  Nick C Fox,et al.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.

[6]  Nick C. Fox,et al.  Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration , 2011, Brain : a journal of neurology.

[7]  Marzena Wojciechowska,et al.  Cellular toxicity of expanded RNA repeats: focus on RNA foci , 2011, Human molecular genetics.

[8]  J. Trojanowski,et al.  A harmonized classification system for FTLD-TDP pathology , 2011, Acta Neuropathologica.

[9]  N. Bogdanovic,et al.  Semantic dementia with lower motor neuron disease showing FTLD‐TDP type 3 pathology (sensu Mackenzie) , 2011, Neuropathology : official journal of the Japanese Society of Neuropathology.

[10]  C. Troakes,et al.  Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP‐43 proteinopathies but are only rarely additionally immunopositive for phosphorylation‐dependent TDP‐43 , 2011, Neuropathology : official journal of the Japanese Society of Neuropathology.

[11]  J. Hodges,et al.  Neuropathological background of phenotypical variability in frontotemporal dementia , 2011, Acta Neuropathologica.

[12]  D. Neary,et al.  The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene , 2011, Acta Neuropathologica.

[13]  Olivier Piguet,et al.  Eating and hypothalamus changes in behavioral-variant frontotemporal dementia , 2011, Annals of neurology.

[14]  D. Neary,et al.  Pathological correlates of frontotemporal lobar degeneration in the elderly , 2011, Acta Neuropathologica.

[15]  D. Hernandez,et al.  Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p , 2011, Journal of Neurology.

[16]  T. Bak Motor neuron disease and frontotemporal dementia: One, two, or three diseases? , 2010, Annals of Indian Academy of Neurology.

[17]  David Heckerman,et al.  Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study , 2010, The Lancet Neurology.

[18]  A. Farmer,et al.  Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study , 2010, The Lancet Neurology.

[19]  J. Hodges,et al.  Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. , 2010, Archives of neurology.

[20]  B. Boeve,et al.  Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  R. Petersen,et al.  FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration , 2010, Acta Neuropathologica.

[22]  J. Hodges,et al.  The case of a 48 year-old woman with bizarre and complex delusions , 2010, Nature Reviews Neurology.

[23]  Teruhiko Inoue,et al.  Clinical entity of frontotemporal dementia with motor neuron disease , 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.

[24]  D. Na,et al.  Semantic dementia combined with motor neuron disease , 2009, Journal of Clinical Neuroscience.

[25]  J. V. van Swieten,et al.  Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration , 2009, Journal of Neurology.

[26]  John Q. Trojanowski,et al.  Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update , 2009, Acta Neuropathologica.

[27]  Ewout J N Groen,et al.  Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis , 2009, Nature Genetics.

[28]  K. Josephs,et al.  The clinical spectrum of stereotypies in frontotemporal lobar degeneration , 2009, Movement disorders : official journal of the Movement Disorder Society.

[29]  S. Heath,et al.  Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease , 2009, Neurology.

[30]  A Danek,et al.  Frontotemporale Lobärdegenerationen , 2009, Fortschritte der Neurologie-Psychiatrie.

[31]  S. Lehéricy,et al.  Démence sémantique associée à une sclérose latérale amyotrophique , 2009 .

[32]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[33]  J L Haines,et al.  Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .

[34]  M. Freedman,et al.  Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[35]  B. Dubois,et al.  Demence semantique associeeaune sclerose laterale amyotrophique Semantic dementia associated with amyotrophic lateral sclerosis , 2009 .

[36]  A. Larner Delusion of Pregnancy in Frontotemporal Lobar Degeneration with Motor Neurone Disease (FTLD/MND) , 2008, Behavioural neurology.

[37]  B. McConkey,et al.  TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis , 2008, Nature Genetics.

[38]  P. Hartikainen,et al.  Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions Visualized With Ubiquitin-Binding Protein p62 Immunohistochemistry , 2008, Journal of neuropathology and experimental neurology.

[39]  Julie S Snowden,et al.  Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. , 2008, Brain : a journal of neurology.

[40]  Julie S. Snowden,et al.  Variability in cognitive presentation of Alzheimer's disease , 2008, Cortex.

[41]  M. Mendez,et al.  Psychotic Symptoms in Frontotemporal Dementia: Prevalence and Review , 2008, Dementia and Geriatric Cognitive Disorders.

[42]  M. Strong The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[43]  E. Lauterbach,et al.  An evidence-based review of the psychopathology of frontotemporal dementia: a report of the ANPA Committee on Research. , 2008, The Journal of neuropsychiatry and clinical neurosciences.

[44]  J. Trojanowski,et al.  Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations , 2008, Acta Neuropathologica.

[45]  Julie S. Snowden,et al.  Cognitive Phenotypes in Alzheimer's Disease and Genetic Risk , 2007, Cortex.

[46]  J. Schneider,et al.  Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration , 2007, Acta Neuropathologica.

[47]  David Mann,et al.  Frontotemporal lobar degeneration: clinical and pathological relationships , 2007, Acta Neuropathologica.

[48]  W. Kamphorst,et al.  TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations. , 2007, Brain : a journal of neurology.

[49]  Roland G Henry,et al.  Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. , 2007, Archives of neurology.

[50]  R. Henry,et al.  Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. , 2007, Archives of neurology.

[51]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[52]  J. Trojanowski,et al.  Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. , 2006, The American journal of pathology.

[53]  Julie S. Snowden,et al.  Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype , 2006, Acta Neuropathologica.

[54]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[55]  H. Horvitz,et al.  A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia , 2006, Neurology.

[56]  D. Neary,et al.  Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[57]  Catherine Lomen-Hoerth,et al.  The overlap of amyotrophic lateral sclerosis and frontotemporal dementia , 2002, Neurology.

[58]  G. Rouleau,et al.  Familial amyotrophic lateral sclerosis , 2002, Muscle & nerve.

[59]  D. Neary,et al.  Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia , 2001, Acta neurologica Scandinavica.

[60]  D. Neary,et al.  Distinct behavioural profiles in frontotemporal dementia and semantic dementia , 2001, Journal of neurology, neurosurgery, and psychiatry.

[61]  J R Hodges,et al.  Selective impairment of verb processing associated with pathological changes in Brodmann areas 44 and 45 in the motor neurone disease-dementia-aphasia syndrome. , 2001, Brain : a journal of neurology.

[62]  M. Catani,et al.  Rapidly progressive aphasic dementia with motor neuron disease: A distinctive clinical entity? , 2000, Neurobiology of Aging.

[63]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[64]  R. Nitrini,et al.  Psychotic symptoms in dementia associated with motor neuron disease: a pathophysiological hypothesis. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[65]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[66]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[67]  P. Talbot Frontal lobe dementia and motor neuron disease. , 1996, Journal of neural transmission. Supplementum.

[68]  D. Neary,et al.  Inter-relation between "classic" motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[69]  R. Petersen,et al.  Rapidly progressive aphasic dementia and motor neuron disease , 1993, Annals of neurology.

[70]  S. M. Sumi,et al.  Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala , 1992, Neurology.

[71]  S. Mellgren,et al.  Familial amyotrophic lateral sclerosis , 1980 .